These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4039368)

  • 1. Synthesis and central dopaminergic effects of N-(4,6-dimethyl-2-pyridinyl)benzamides.
    Bouhayat S; Piessard S; Le Baut G; Sparfel L; Petit JY; Piriou F; Welin L
    J Med Chem; 1985 May; 28(5):555-9. PubMed ID: 4039368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors.
    Vasse M; Protais P
    Neuropharmacology; 1989 Sep; 28(9):931-9. PubMed ID: 2554186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzamide potentiation of behavioral apomorphine-induced effects; mechanism involved.
    Piriou F; Petit JY; Welin L
    Experientia; 1985 Nov; 41(11):1409-10. PubMed ID: 2998860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypy.
    Feigenbaum JJ; Yanai J; Blass RB; Moon B; Klawans H
    Pharmacol Biochem Behav; 1982 Feb; 16(2):235-40. PubMed ID: 7200236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan).
    Costall B; Naylor RJ
    Psychopharmacologia; 1975 Jul; 43(1):53-61. PubMed ID: 1099605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
    Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REM sleep deprivation decreases apomorphine-induced stimulation of locomotor activity but not stereotyped behavior in mice.
    Asakura W; Matsumoto K; Ohta H; Watanabe H
    Gen Pharmacol; 1992 May; 23(3):337-41. PubMed ID: 1511844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP.
    Hjorth S; Svensson K; Carlsson A; Wikström H; Andersson B
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):205-18. PubMed ID: 3762735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanisms.
    Jenner P; Clow A; Reavill C; Theodorou A; Marsden CD
    J Pharm Pharmacol; 1980 Jan; 32(1):39-44. PubMed ID: 6102125
    [No Abstract]   [Full Text] [Related]  

  • 11. Circling behaviour induced by electrical stimulation of the medial forebrain bundle, importance of stimulus parameters and dopaminergic processes.
    van der Heyden JA
    Pharmacol Biochem Behav; 1984 Oct; 21(4):567-74. PubMed ID: 6334318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yawning and suppression of exploration induced by dopamine agonists: no relation to extracellular striatal levels of dopamine.
    Ståhle L; Ungerstedt U
    Pharmacol Biochem Behav; 1990 Jan; 35(1):201-9. PubMed ID: 1969163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
    Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
    Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid development of hypersensitivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitors.
    Costentin J; Marçais H; Protais P; Baudry M; De La Baume S; Martres MP; Schwartz JC
    Life Sci; 1977 Aug; 21(3):307-13. PubMed ID: 561281
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of prenatal diphenhydramine exposure on dopaminergic function in adult rats.
    Chiavegatto S; Bernardi MM
    Pharmacol Biochem Behav; 1991 Sep; 40(1):191-3. PubMed ID: 1780341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subsensitivity of striatal and mesolimbic dopamine target cells after repeated treatment with apomorphine dipivaloyl ester.
    Scatton B; Worms P
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):271-8. PubMed ID: 567284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS dopamine autoreceptors: distribution, pharmacology, and function.
    Roth RH
    Ann N Y Acad Sci; 1984; 430():27-53. PubMed ID: 6378032
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological profiles of three new, potent and selective dopamine receptor agonists: N-0434, N-0437 and N-0734.
    Van der Weide J; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1986 Jun; 125(2):273-82. PubMed ID: 3743637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
    Cools AR; van Rossum JM
    Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.